Pancreatitis risk: There is a potential risk of pancreatitis associated with tirzepatide use
What to Expect: A Realistic Timeline on GLP-1 Medication Weeks 14: Dose escalation begins at 0.25 mg/week
Just search for "Glapp" or visit our store pages
But, thinking about what we do, I feel good about navigating patients towards the best available treatment for them." Botta also is concerned about patients' access to "life-changing" weight loss medications if supply issues aren't resolved
For additional product-specific information on agents from the GLP-1 RA class, please refer to the companion lesson titled: An Overview of GLP-1 RAs: What Every Pharmacist Should Know. PUTTING IT ALL TOGETHER: CASE REVIEW AND DISCUSSION Case scenario JM is a 65-year-old man with T2D of 8 years duration
GLP-1 medications reduce physical hunger but do not directly treat binge eating behaviors, emotional eating triggers, or psychological factors that contribute to overeating